Influenza A H3N2
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain (NCT06613737) | Hvivo | 2024-09-11 |
| A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus (NCT06385821) | NPO Petrovax | 2022-09-21 |
| Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus) (NCT04204993) | Imperial College London | 2020-02-11 |
| Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults (NCT03743688) | Vanderbilt University Medical Center | 2018-12-04 |
| Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A (NCT03315104) | Emergent BioSolutions | 2017-11-17 |
| Study Examining PrEP-001 in Healthy Subjects (NCT03220048) | Hvivo | 2015-09-16 |
Track Influenza A H3N2 automatically
Every clearance here is in the API, with alerts when new ones post.